Generic group sues Minnesota over a drug pricing transparency legislation

The commerce group for generic drug corporations has filed a lawsuit alleging a Minnesota legislation that’s designed to offer transparency into prescription drug pricing is unconstitutional, the most recent effort to push again towards states trying to decrease the price of medicines.

In its lawsuit, the Affiliation for Accessible Medicines claimed the legislation is an “unconstitutional overreach,” as a result of it offers the state the facility to control interstate commerce and apply Minnesota legislation to costs charged in different states. The commerce group additionally contended the legislation violates the constitutional proper to due course of as a result of the state has the correct to file lawsuits over out-of-state transactions.

“Below the brand new price-control legislation, AAM’s members shall be uncovered to huge civil penalties and different financial legal responsibility for promoting their merchandise at costs deemed by the (legislation) to be unacceptable, even when charged wholly exterior Minnesota,” the lawsuit alleged. The commerce group argued the “draconian laws” come at a time when the generic business is “already present process extreme monetary pressure.”